In recent years, studies have found that TanIIA plays an active role in the prevention and treatment of AD, mainly in the inhibition of the formation and aggregation of Aβ, the inhibition of abnormal phosphorylation of tau protein, and the protection of neurons (Li Y. et al., 2017). Here, MAPT is linked to Alzheimer disease.